Tenofovir Alafenamide is a nucleoside analog reverse transcriptase inhibitor used for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease. Tenofovir alafenamide is a novel tenofovir prodrug developed to improve renal safety when compared to the counterpart tenofovir disoproxil. Tenofovir alafenamide is a prodrug of tenofovir. Synthink is a most trusted source of Tenofovir Alafenamide Degradation
Impurity, Tenofovir Alafenamide Genotoxic impurity, Tenofovir Alafenamide Process Impurity, USP related compound, Tenofovir Alafenamide Nitrosamine impurity, N-Nitroso impurity etc. which are listed on this page.